140 related articles for article (PubMed ID: 29425137)
21. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
Tong L; Guo L; Lv X; Li Y
J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
[TBL] [Abstract][Full Text] [Related]
22. Two xanthones from Polygala paniculata and confirmation of the 1-hydroxy-2,3,5-trimethoxy-xanthone at trace level by HRGC-MS.
Cristiano R; Pizzolatti MG; Delle Monache F; Rezende CM; Branco A
Z Naturforsch C J Biosci; 2003; 58(7-8):490-4. PubMed ID: 12939033
[TBL] [Abstract][Full Text] [Related]
23. Molecular modeling studies of [6,6,5] Tricyclic Fused Oxazolidinones as FXa inhibitors using 3D-QSAR, Topomer CoMFA, molecular docking and molecular dynamics simulations.
Xu C; Ren Y
Bioorg Med Chem Lett; 2015 Oct; 25(20):4522-8. PubMed ID: 26343829
[TBL] [Abstract][Full Text] [Related]
24. A systematic quantitative approach to rational drug design and discovery of novel human carbonic anhydrase IX inhibitors.
Sethi KK; Verma SM
J Enzyme Inhib Med Chem; 2014 Aug; 29(4):571-81. PubMed ID: 24090419
[TBL] [Abstract][Full Text] [Related]
25. CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors.
Ul-Haq Z; Wadood A; Uddin R
J Enzyme Inhib Med Chem; 2009 Feb; 24(1):272-8. PubMed ID: 18608766
[TBL] [Abstract][Full Text] [Related]
26. Insight into the structural requirements of proton pump inhibitors based on CoMFA and CoMSIA studies.
Nayana MR; Sekhar YN; Nandyala H; Muttineni R; Bairy SK; Singh K; Mahmood SK
J Mol Graph Model; 2008 Oct; 27(3):233-43. PubMed ID: 18676164
[TBL] [Abstract][Full Text] [Related]
27. Xanthine oxidase inhibitors from Garcinia esculenta twigs.
Zhu LL; Fu WW; Watanabe S; Shao YN; Tan HS; Zhang H; Tan CH; Xiu YF; Norimoto H; Xu HX
Planta Med; 2014 Dec; 80(18):1721-6. PubMed ID: 25340468
[TBL] [Abstract][Full Text] [Related]
28. An in-depth view of potential dual effect of thymol in inhibiting xanthine oxidase activity: Electrochemical measurements in combination with four way PARAFAC analysis and molecular docking insights.
Abbasi S; Gharaghani S; Benvidi A; Rezaeinasab M; Saboury AA
Int J Biol Macromol; 2018 Nov; 119():1298-1310. PubMed ID: 30096398
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, molecular docking and xanthine oxidase inhibitory activity of 5-aryl-1H-tetrazoles.
Fatima I; Zafar H; Khan KM; Saad SM; Javaid S; Perveen S; Choudhary MI
Bioorg Chem; 2018 Sep; 79():201-211. PubMed ID: 29772470
[TBL] [Abstract][Full Text] [Related]
30. Structure-Activity Relationships and Docking Studies of Hydroxychavicol and Its Analogs as Xanthine Oxidase Inhibitors.
Nishiwaki K; Ohigashi K; Deguchi T; Murata K; Nakamura S; Matsuda H; Nakanishi I
Chem Pharm Bull (Tokyo); 2018 Jul; 66(7):741-747. PubMed ID: 29695658
[TBL] [Abstract][Full Text] [Related]
31. Screening of xanthine oxidase inhibitors in complex mixtures using online HPLC coupled with postcolumn fluorescence-based biochemical detection.
Li D; Li S; Zhao J
J Sep Sci; 2014 Feb; 37(4):338-44. PubMed ID: 24347507
[TBL] [Abstract][Full Text] [Related]
32. Studies on [5,6]-Fused Bicyclic Scaffolds Derivatives as Potent Dual B-RafV600E/KDR Inhibitors Using Docking and 3D-QSAR Approaches.
Liu HC; Tang SZ; Lu S; Ran T; Wang J; Zhang YM; Xu AY; Lu T; Chen YD
Int J Mol Sci; 2015 Oct; 16(10):24451-74. PubMed ID: 26501259
[TBL] [Abstract][Full Text] [Related]
33. Computational Analysis of CRTh2 receptor antagonist: A Ligand-based CoMFA and CoMSIA approach.
Babu S; Sohn H; Madhavan T
Comput Biol Chem; 2015 Jun; 56():109-21. PubMed ID: 25935115
[TBL] [Abstract][Full Text] [Related]
34. 3D-QSAR Studies on C24-Monoalkylated Vitamin D3 26,23-Lactones and their C2α-Modified Derivatives with Inhibitory Activity to Vitamin D Receptor.
Wang J; Tang K; Hou Q; Cheng X; Dong L; Liu Y; Liu C
Mol Inform; 2010 Sep; 29(8-9):621-32. PubMed ID: 27463456
[TBL] [Abstract][Full Text] [Related]
35. In silico study on β-aminoketone derivatives as thyroid hormone receptor inhibitors: a combined 3D-QSAR and molecular docking study.
Wang FF; Yang W; Shi YH; Le GW
J Biomol Struct Dyn; 2016 Dec; 34(12):2619-2631. PubMed ID: 26618241
[TBL] [Abstract][Full Text] [Related]
36. 3D-QSAR (CoMFA, CoMSIA), molecular docking and molecular dynamics simulations study of 6-aryl-5-cyano-pyrimidine derivatives to explore the structure requirements of LSD1 inhibitors.
Ding L; Wang ZZ; Sun XD; Yang J; Ma CY; Li W; Liu HM
Bioorg Med Chem Lett; 2017 Aug; 27(15):3521-3528. PubMed ID: 28610981
[TBL] [Abstract][Full Text] [Related]
37. Docking-based CoMFA and CoMSIA studies on naphthyl-substituted diarylpyrimidines as NNRTIs.
Wu HQ; Yao J; He QQ; Chen FE
SAR QSAR Environ Res; 2014; 25(10):761-75. PubMed ID: 25242254
[TBL] [Abstract][Full Text] [Related]
38. Design and synthesis of novel 2-(indol-5-yl)thiazole derivatives as xanthine oxidase inhibitors.
Song JU; Choi SP; Kim TH; Jung CK; Lee JY; Jung SH; Kim GT
Bioorg Med Chem Lett; 2015 Mar; 25(6):1254-8. PubMed ID: 25704891
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, inhibitory activities, and QSAR study of xanthone derivatives as alpha-glucosidase inhibitors.
Liu Y; Ke Z; Cui J; Chen WH; Ma L; Wang B
Bioorg Med Chem; 2008 Aug; 16(15):7185-92. PubMed ID: 18632275
[TBL] [Abstract][Full Text] [Related]
40. QSAR and molecular docking studies on oxindole derivatives as VEGFR-2 tyrosine kinase inhibitors.
Kang CM; Liu DQ; Zhao XH; Dai YJ; Cheng JG; Lv YT
J Recept Signal Transduct Res; 2016; 36(1):103-9. PubMed ID: 26416217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
